Modus Therapeutics Holding AB (OSTO:MODTX) Days Payable: 0.00 (As of Mar. 2026)


OSTO:MODTX Modus Therapeutics Holding AB OSTO:MODTX
25 GF Score
Price kr0.38
! 1 Warning Sign
View Full Analysis

What is Modus Therapeutics Holding AB Days Payable?

Modus Therapeutics Holding AB OSTO:MODTX +1.60% 25 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates OSTO:MODTX with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 703 Biotechnology companies, Modus Therapeutics Holding AB ranks worse than 142247.37% on this metric.

Modus Therapeutics Holding AB's average Accounts Payable for the three months ended in Mar. 2026 was kr1.61 Mil. Modus Therapeutics Holding AB's Cost of Goods Sold for the three months ended in Mar. 2026 was kr0.00 Mil.

The historical rank and industry rank for Modus Therapeutics Holding AB's Days Payable or its related term are showing as below:

OSTO:MODTX's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.76
* Ranked among companies with meaningful Days Payable only.

Modus Therapeutics Holding AB's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Modus Therapeutics Holding AB Days Payable Historical Data

* Premium members only.

The historical data trend for Modus Therapeutics Holding AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modus Therapeutics Holding AB Days Payable Chart

Modus Therapeutics Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Modus Therapeutics Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSTO:MODTX vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Modus Therapeutics Holding AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modus Therapeutics Holding AB Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Modus Therapeutics Holding AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Modus Therapeutics Holding AB's Days Payable falls into.


OSTO:MODTX
25GF Score
Modus Therapeutics Holding AB OSTO:MODTX
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modus Therapeutics Holding AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Modus Therapeutics Holding AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (1.555 + 2.274) / 2 ) / 0*365
=1.9145 / 0*365
=N/A

Modus Therapeutics Holding AB's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (2.274 + 0.943) / 2 ) / 0*365 / 4
=1.6085 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Modus Therapeutics Holding AB (OSTO:MODTX) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Modus Therapeutics Holding AB and its competitors. According to the industry distribution chart, Modus Therapeutics Holding AB ranks #999999 out of 703 companies in the Biotechnology industry.
Is Modus Therapeutics Holding AB's Days Payable too high?
Modus Therapeutics Holding AB's current Days Payable is 0.00. Based on the distribution chart, Modus Therapeutics Holding AB ranks #999999 out of 703 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Modus Therapeutics Holding AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Modus Therapeutics Holding AB's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Modus Therapeutics Holding AB ranks #999999 out of 703 companies for Days Payable. This places Modus Therapeutics Holding AB in the lower half of its industry. The industry median Days Payable is 113.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Modus Therapeutics Holding AB and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modus Therapeutics Holding AB's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modus Therapeutics Holding AB stock overvalued right now?
Modus Therapeutics Holding AB (OSTO:MODTX) has a current Days Payable of 0.00. The current Days Payable is 0.00. Modus Therapeutics Holding AB's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Modus Therapeutics Holding AB (OSTO:MODTX), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modus Therapeutics Holding AB Business Description

Address Olof Palmes gata 29 IV, Stockholm, SWE, 111 22
Modus Therapeutics Holding AB is a Swedish biotechnology company developing its patented polysaccharide, sevuparin, as a potential treatment for unmet medical needs. Its research focuses on conditions involving severe systemic inflammation, including sepsis and septic shock, severe malaria, and other related disorders, as well as anemia associated with chronic inflammatory conditions such as kidney disease.
25GF Score

Get the complete analysis for OSTO:MODTX

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.38
Price